Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Dispenzieri

Showing results (51-60 of 154) with videos related to

Pageof 16
Sort By:
Leukemia|August 2, 2001
Thalidomide for previously untreated indolent or smoldering multiple myelomaS V Rajkumar, A Dispenzieri, R Fonseca, et al.
American Journal of Hematology|January 5, 2002
Methods for estimation of bone marrow plasma cell involvement in myeloma: predictive value for response and survival in patients undergoing autologous stem cell transplantationS V Rajkumar, R Fonseca, A Dispenzieri, et al.
Neurology|March 17, 2010
Stem cell transplantation in patients with autonomic neuropathy due to primary (AL) amyloidosisD Dingli, T S Tan, S K Kumar, et al.
Bone Marrow Transplantation|November 11, 2008
Comparison of high-dose CY and growth factor with growth factor alone for mobilization of stem cells for transplantation in patients with multiple myelomaM A Gertz, S K Kumar, M Q Lacy, et al.
Heart (British Cardiac Society)|May 14, 2008
'Hypersynchronisation' by tissue velocity imaging in patients with cardiac amyloidosisD Bellavia, P A Pellikka, T P Abraham, et al.
Leukemia|February 26, 2011
Incidence of extramedullary disease in patients with multiple myeloma in the era of novel therapy, and the activity of pomalidomide on extramedullary myelomaK Detweiler Short, S V Rajkumar, D Larson, et al.
Bone Marrow Transplantation|August 23, 2016
The impact of induction regimen on transplant outcome in newly diagnosed multiple myeloma in the era of novel agentsR Chakraborty, E Muchtar, S Kumar, et al.
Leukemia|June 22, 2007
Impact of lenalidomide therapy on stem cell mobilization and engraftment post-peripheral blood stem cell transplantation in patients with newly diagnosed myelomaS Kumar, A Dispenzieri, M Q Lacy, et al.
Bone Marrow Transplantation|April 16, 2014
Accuracy of self-reported tobacco use status among hematopoietic SCT patientsS L Ehlers, C A Bronars, C A Patten, et al.
Journal of Internal Medicine|September 15, 2020
Systemic amyloidosis from A (AA) to T (ATTR): a reviewE Muchtar, A Dispenzieri, H Magen, et al.
Pageof 16

Showing results (51-60 of 154) with videos related to

Sort By:
Pageof 16
Leukemia|August 2, 2001
Thalidomide for previously untreated indolent or smoldering multiple myelomaS V Rajkumar, A Dispenzieri, R Fonseca, et al.
American Journal of Hematology|January 5, 2002
Methods for estimation of bone marrow plasma cell involvement in myeloma: predictive value for response and survival in patients undergoing autologous stem cell transplantationS V Rajkumar, R Fonseca, A Dispenzieri, et al.
Neurology|March 17, 2010
Stem cell transplantation in patients with autonomic neuropathy due to primary (AL) amyloidosisD Dingli, T S Tan, S K Kumar, et al.
Bone Marrow Transplantation|November 11, 2008
Comparison of high-dose CY and growth factor with growth factor alone for mobilization of stem cells for transplantation in patients with multiple myelomaM A Gertz, S K Kumar, M Q Lacy, et al.
Heart (British Cardiac Society)|May 14, 2008
'Hypersynchronisation' by tissue velocity imaging in patients with cardiac amyloidosisD Bellavia, P A Pellikka, T P Abraham, et al.
Leukemia|February 26, 2011
Incidence of extramedullary disease in patients with multiple myeloma in the era of novel therapy, and the activity of pomalidomide on extramedullary myelomaK Detweiler Short, S V Rajkumar, D Larson, et al.
Bone Marrow Transplantation|August 23, 2016
The impact of induction regimen on transplant outcome in newly diagnosed multiple myeloma in the era of novel agentsR Chakraborty, E Muchtar, S Kumar, et al.
Leukemia|June 22, 2007
Impact of lenalidomide therapy on stem cell mobilization and engraftment post-peripheral blood stem cell transplantation in patients with newly diagnosed myelomaS Kumar, A Dispenzieri, M Q Lacy, et al.
Bone Marrow Transplantation|April 16, 2014
Accuracy of self-reported tobacco use status among hematopoietic SCT patientsS L Ehlers, C A Bronars, C A Patten, et al.
Journal of Internal Medicine|September 15, 2020
Systemic amyloidosis from A (AA) to T (ATTR): a reviewE Muchtar, A Dispenzieri, H Magen, et al.
Pageof 16